SPAGGIARI, LORENZO
SPAGGIARI, LORENZO
Dipartimento di Oncologia ed Emato-Oncologia
Characterizing the Learning Curve of ION Robotic Bronchoscopy: A CUSUM-Based Analysis of Diagnostic Yield
2026 J. Guarize, L. Bertolaccini, C. Bardoni, S.M. Donghi, L. Spaggiari
Surgical Outcomes After Neoadjuvant Chemo-Immunotherapy for Stage III NSCLC: A Systematic Review and Meta-Analysis
2025 C. Bardoni, M. Chiari, L. Bertolaccini, C. Diotti, A. De Fabiani, G. Nicolosi, A. Mazzella, M. Casiraghi, L. Spaggiari
Recommendations for the standardization and management of prolonged air leaks in lung surgery
2025 F. Zaraca, M.D. Pipitone, F. Augustin, A. Abdellateef, M. Jiménez, A. Kirschbaum, C.S.H. Ng, D. Nachira, I. Opitz, C. Uslenghi, M. Lucchi, R. Crisci, R. Perkmann, L. Spaggiari, L. Bertolaccini
The Actual Role of CPET in Predicting Postoperative Morbidity and Mortality of Patients Undergoing Pneumonectomy
2025 A. Mazzella, R. Orlandi, P. Maisonneuve, C. Uslenghi, M. Chiari, M. Casiraghi, L. Bertolaccini, G. Caffarena, L. Spaggiari
PREDICTIVE SCORE FOR LOCAL RELAPSE AFTER PULMONARY METASTASECTOMY
2025 E. Prisciandaro, L. Bertolaccini, S. Fieuws, A. Cara, L. Spaggiari, L. Huang, R.H. Petersen, M. Lucchi, M.G. Mastromarino, A. Barbarossa, P. De Leyn, M. Roffinella, E. Ruffini, A. Donlagic, M. Gonzalez, M.G. Fuentes-Gago, C. Forcada-Barreda, M.T. Congedo, S. Margaritora, Y. Belaroussi, M. Thumerel, J. Tricard, P. Felix, N. Lebeda, I. Opitz, A. De Palma, G. Marulli, C. Braggio, P.A. Thomas, F. Mbadinga, J.-. Baste, B. Sayan, B. Yildizeli, J. Dekervel, D.E. Van Raemdonck, W. Weder, L.J. Ceulemans
The Short-Term Impact of Neoadjuvant Chemotherapy on the Outcome of Patients Undergoing Pneumonectomy for Lung Cancer: Is It Acceptable Nowadays?
2025 A. Mazzella, S. Maiorca, G. Nicolosi, P. Maisonneuve, A. Passaro, M. Casiraghi, L. Bertolaccini, F. De Marinis, L. Spaggiari
Redefining resectability: Bridging perspectives in stage III NSCLC management
2025 L. Bertolaccini, M. Casiraghi, A. Mazzella, L. Spaggiari
Clinicopathological Features and Prognosis of Lung Adenocarcinoma Presenting as Ground-Glass Opacity: A Single-Center Experience
2025 M. Casiraghi, L. Girelli, A. Elettore, L. Bertolaccini, A. Mazzella, C. Bardoni, M. Lombardi, V. Midolo, G. Petralia, P. Maisonneuve, J. Guarize, L. Spaggiari
Robotic thymectomy for large thymomas: a multicenter study
2025 D. Nachira, M.T. Congedo, L. Bertolaccini, P. Novellis, P. Bertoglio, A. De Palma, R. Romano, F. Raveglia, K. Kuzmych, A. Senatore, M. Chiari, S. Maiorca, C. Scala, M. Petroncini, D. Brascia, G. Carleo, F. Spinelli, F. Petrella, F. Lococo, D. Gavezzoli, J. Brandolini, G. Marulli, G. Veronesi, L. Spaggiari, S. Margaritora, E. Meacci
Biological staging in early-stage non-small-cell lung cancer: molecular risk-guided adjuvant therapy
2025 L. Bertolaccini, L. Spaggiari
Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma: signal or noise?
2025 L. Bertolaccini, F. De Marinis, L. Spaggiari
Correction to: Robotic thymectomy for large thymomas: a multicenter study
2025 D. Nachira, M.T. Congedo, L. Bertolaccini, P. Novellis, P. Bertoglio, A. De Palma, R. Romano, F. Raveglia, K. Kuzmych, A. Senatore, M. Chiari, S. Maiorca, C. Scala, M. Petroncini, D. Brascia, G. Carleo, F. Spinelli, F. Petrella, F. Lococo, D. Gavezzoli, P. Solli, J. Brandolini, G. Marulli, G. Veronesi, L. Spaggiari, S. Margaritora, E. Meacci
The impact of SMARCA4 loss in non-small cell lung cancer therapy
2025 M. Lombardi, M. D'Ercole, V. Midolo De Luca, M. Chiari, L. Spaggiari, L. Bertolaccini
10-Year Long-Term Outcomes of Robotic-Assisted Segmentectomy for Early-Stage Non-Small-Cell Lung Cancer
2025 M. Casiraghi, R. Orlandi, A. Mazzella, L. Girelli, G. Caffarena, M. Chiari, L. Bertolaccini, G. Lo Iacono, C. Diotti, C. Bardoni, P. Maisonneuve, L. Spaggiari
Vetus Sed Utilis: Open Window Thoracostomy after Lung Surgery
2025 A. Mazzella, C. Bardoni, L. Bertolaccini, M. Casiraghi, L. Girelli, G.L. Iacono, L. Spaggiari
Diverging trends in lung cancer: a 26-year analysis of sex-specific patterns and histological shifts in Northern Italy
2025 L. Bertolaccini, C. Santucci, C. La Vecchia, F. Toffolutti, G. Corso, L. Spaggiari, D. Serraino
Safety and Efficacy of Salvage Surgery after Treatment With Immune-Checkpoint Adjuvant Inhibitors for Advanced Non-Small Cell Lung Cancer: A Multicentric Study
2025 M. Schiavon, G. Cannone, L. Bertolaccini, F.T. Gallina, F. Pezzuto, G. Lorenzoni, F. Facciolo, L. Spaggiari, F. Calabrese, F. Rea, G. Pasello
Impact of Surgical extent on survival in pulmonary typical carcinoids: a retrospective analysis
2025 L. Bertolaccini, L. Benini, F. Spada, E. Pisa, R. Lobrano, J. Guarize, G. Caffarena, M. Chiari, M. Casiraghi, N. Fazio, L. Spaggiari
Raising the bar: evaluating quality and consistency in clinical guidelines for surgical management of pulmonary carcinoid
2025 L. Bertolaccini, C. Bardoni, G. Caffarena, M. Chiari, C. Diotti, A. Mazzella, L. Benini, F. Spada, G. Corso, E. Pisa, M. Casiraghi, N. Fazio, L. Spaggiari
Fast Track Pathway for Lung Cancer: The Integration of ION Robotic-Assisted Bronchoscopy With Robotic Thoracic Surgical Resection
2025 J. Guarize, L. Bertolaccini, L. Spaggiari